Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.

Chen HC, Chen YL, Guo BF, Tsai TH, Chang JP, Pan KL, Lin YS, Chen MC.

Can J Cardiol. 2013 Sep;29(9):1110-7. doi: 10.1016/j.cjca.2012.12.014. Epub 2013 Mar 6.

PMID:
23474139
[PubMed - indexed for MEDLINE]
2.

Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.

Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA.

J Am Coll Cardiol. 2010 May 25;55(21):2376-82. doi: 10.1016/j.jacc.2009.12.056.

PMID:
20488310
[PubMed - indexed for MEDLINE]
Free Article
3.

The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.

Thal S, Moukabary T, Boyella R, Shanmugasundaram M, Pierce MK, Thai H, Goldman S.

Pacing Clin Electrophysiol. 2010 Apr;33(4):385-8. doi: 10.1111/j.1540-8159.2009.02674.x. Epub 2010 Jan 4.

PMID:
20059711
[PubMed - indexed for MEDLINE]
4.

Risk of hematoma complications after device implant in the clopidogrel era.

Kutinsky IB, Jarandilla R, Jewett M, Haines DE.

Circ Arrhythm Electrophysiol. 2010 Aug;3(4):312-8. doi: 10.1161/CIRCEP.109.917625. Epub 2010 Jun 17.

PMID:
20558847
[PubMed - indexed for MEDLINE]
Free Article
5.

Influence of oral antiplatelet therapy on hemorrhagic complications of pacemaker implantation.

Said SM, Esperer HD, Hahn J, Bollmann A, Richter S, Rauwolf T, Prondzinsky R, Schmeisser A, Braun-Dullaeus RC.

Clin Res Cardiol. 2013 May;102(5):345-9. doi: 10.1007/s00392-013-0543-8. Epub 2013 Feb 6.

PMID:
23386254
[PubMed - indexed for MEDLINE]
6.

Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.

Ghanbari H, Feldman D, Schmidt M, Ottino J, Machado C, Akoum N, Wall TS, Daccarett M.

Pacing Clin Electrophysiol. 2010 Apr;33(4):400-6. doi: 10.1111/j.1540-8159.2010.02703.x. Epub 2010 Feb 18.

PMID:
20180915
[PubMed - indexed for MEDLINE]
7.

Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.

Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK.

J Invasive Cardiol. 2006 Apr;18(4):162-4.

PMID:
16729401
[PubMed - indexed for MEDLINE]
8.

Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.

DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.

Pharmacotherapy. 2007 May;27(5):691-6.

PMID:
17461704
[PubMed - indexed for MEDLINE]
9.

Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices.

Korantzopoulos P, Letsas KP, Liu T, Fragakis N, Efremidis M, Goudevenos JA.

Europace. 2011 Dec;13(12):1669-80. doi: 10.1093/europace/eur210. Epub 2011 Jul 25. Review.

PMID:
21788280
[PubMed - indexed for MEDLINE]
Free Article
10.

Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial.

Nammas W, Raatikainen MJ, Korkeila P, Lund J, Ylitalo A, Karjalainen P, Virtanen V, Koivisto UM, Utriainen S, Vasankari T, Koistinen J, Airaksinen KE.

Ann Med. 2014 May;46(3):177-81. doi: 10.3109/07853890.2014.894285.

PMID:
24785546
[PubMed - indexed for MEDLINE]
11.

No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.

Li HK, Chen FC, Rea RF, Asirvatham SJ, Powell BD, Friedman PA, Shen WK, Brady PA, Bradley DJ, Lee HC, Hodge DO, Slusser JP, Hayes DL, Cha YM.

Pacing Clin Electrophysiol. 2011 Jul;34(7):868-74. doi: 10.1111/j.1540-8159.2011.03049.x. Epub 2011 Mar 16.

PMID:
21410724
[PubMed - indexed for MEDLINE]
12.

Pacemaker or defibrillator surgery without interruption of anticoagulation.

Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V; BRUISE CONTROL Investigators.

N Engl J Med. 2013 May 30;368(22):2084-93. doi: 10.1056/NEJMoa1302946. Epub 2013 May 9.

PMID:
23659733
[PubMed - indexed for MEDLINE]
Free Article
13.

[Antiplatelet agents increase hemorrhagic risk in patients undergoing a cardiac pacemaker or ICD implantation].

Amara W, Ben Youssef I, Monsel F, Sergent J.

Ann Cardiol Angeiol (Paris). 2011 Nov;60(5):267-71. doi: 10.1016/j.ancard.2011.08.006. Epub 2011 Aug 26. French.

PMID:
21924701
[PubMed - indexed for MEDLINE]
14.

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.

Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.

Am Heart J. 2004 Mar;147(3):463-7.

PMID:
14999195
[PubMed - indexed for MEDLINE]
15.

Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.

Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD.

Am Heart J. 2009 Aug;158(2):252-6. doi: 10.1016/j.ahj.2009.06.005.

PMID:
19619702
[PubMed - indexed for MEDLINE]
16.

Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.

Wiegand UK, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, Bode F.

Chest. 2004 Oct;126(4):1177-86.

PMID:
15486380
[PubMed - indexed for MEDLINE]
17.

Outcomes associated with combined antiplatelet and anticoagulant therapy.

Johnson SG, Rogers K, Delate T, Witt DM.

Chest. 2008 Apr;133(4):948-54. doi: 10.1378/chest.07-2627. Epub 2008 Jan 15.

PMID:
18198244
[PubMed - indexed for MEDLINE]
18.

Hematoma complicating permanent pacemaker implantation: the role of periprocedural antiplatelet or anticoagulant therapy.

Özcan KS, Osmonov D, Yıldırım E, Altay S, Türkkan C, Ekmekçi A, Güngör B, Erdinler I.

J Cardiol. 2013 Aug;62(2):127-30. doi: 10.1016/j.jjcc.2013.03.002. Epub 2013 Apr 21.

PMID:
23611169
[PubMed - indexed for MEDLINE]
Free Article
19.

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, Kuntz RE.

N Engl J Med. 1998 Dec 3;339(23):1665-71.

PMID:
9834303
[PubMed - indexed for MEDLINE]
Free Article
20.

Pocket related complications in 163 patients receiving anticoagulation or dual antiplatelet therapy: D-Stat Hemostat versus standard of care.

Ohlow MA, Lauer B, Buchter B, Schreiber M, Geller JC.

Int J Cardiol. 2012 Sep 6;159(3):177-80. doi: 10.1016/j.ijcard.2011.02.042. Epub 2011 Mar 4.

PMID:
21376404
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk